# A Healthy Volunteer Study to Investigate the Blood Concentrations, the Effect on Blood Clotting and the Safety of Multiple Doses of DPOC-4088 Tablets in Different Doses.

> **NCT01647620** · PHASE1 · TERMINATED · sponsor: **Diakron Pharmaceuticals** · enrollment: 30 (estimated)

## Conditions studied

- Deep Vein Thrombosis Leg
- Stroke (in Patients With Atrial Fibrillation)

## Interventions

- **DRUG:** DPOC-4088
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01647620
- **Lead sponsor:** Diakron Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-02
- **Primary completion:** 2012-09
- **Final completion:** 2012-09
- **Target enrollment:** 30 (ESTIMATED)
- **Why stopped:** Diakron Pharmaceuticals couldn't fulfill the financial responsibility of the study
- **Last updated:** 2015-02-24

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01647620

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01647620, "A Healthy Volunteer Study to Investigate the Blood Concentrations, the Effect on Blood Clotting and the Safety of Multiple Doses of DPOC-4088 Tablets in Different Doses.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01647620. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*